Stephen Cohen Biography and Net Worth



Stephen Brad Cohen serves as Co-Founder, Executive Vice President - Strategic Initiatives and Dermatology Sales of the Company. Mr. Cohen served as Regional Sales Manager for Xoft Inc., a medical device company that develops and commercializes miniaturized electronic brachytherapy (eBx) technology for radiation oncology applications, from 2008 to 2009. Prior to that, Mr. Cohen’s medical device sales and marketing experience includes having served as Regional Sales Manager for Diasonics, a developer and manufacturer of ultrasound and other medical imaging equipment, from 1985 to 1988, and from 1983 to 1985, as Regional Sales Manager for Technicare, a developer of CT, DR and MRI scanners and other medical imaging equipment that was acquired by Johnson and Johnson in 1986. Mr. Cohen has a bachelor’s degree from the University of Texas at Austin.

What is Stephen Brad Cohen's net worth?

The estimated net worth of Stephen Brad Cohen is at least $3.14 million as of June 19th, 2018. Mr. Cohen owns 955,023 shares of Sensus Healthcare stock worth more than $3,142,026 as of April 20th. This net worth estimate does not reflect any other assets that Mr. Cohen may own. Learn More about Stephen Brad Cohen's net worth.

How do I contact Stephen Brad Cohen?

The corporate mailing address for Mr. Cohen and other Sensus Healthcare executives is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. Sensus Healthcare can also be reached via phone at (561) 922-5808 and via email at [email protected]. Learn More on Stephen Brad Cohen's contact information.

Has Stephen Brad Cohen been buying or selling shares of Sensus Healthcare?

Stephen Brad Cohen has not been actively trading shares of Sensus Healthcare during the last quarter. Most recently, Stephen Brad Cohen sold 5,321 shares of the business's stock in a transaction on Thursday, December 16th. The shares were sold at an average price of $7.06, for a transaction totalling $37,566.26. Learn More on Stephen Brad Cohen's trading history.

Who are Sensus Healthcare's active insiders?

Sensus Healthcare's insider roster includes Stephen Cohen (EVP), and Joseph Sardano (CEO). Learn More on Sensus Healthcare's active insiders.

Are insiders buying or selling shares of Sensus Healthcare?

In the last twelve months, Sensus Healthcare insiders bought shares 8 times. They purchased a total of 52,511 shares worth more than $164,010.45. The most recent insider tranaction occured on September, 14th when CEO Joseph C Sardano bought 10,000 shares worth more than $28,800.00. Insiders at Sensus Healthcare own 11.1% of the company. Learn More about insider trades at Sensus Healthcare.

Information on this page was last updated on 9/14/2023.

Stephen Brad Cohen Insider Trading History at Sensus Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2021Sell5,321$7.06$37,566.26View SEC Filing Icon  
12/14/2021Sell14,889$7.22$107,498.58View SEC Filing Icon  
12/9/2021Sell22,633$7.81$176,763.73View SEC Filing Icon  
3/22/2019Sell595$7.50$4,462.50View SEC Filing Icon  
6/19/2018Sell2,626$7.57$19,878.82955,023View SEC Filing Icon  
8/28/2017Sell3,908$6.00$23,448.00983,583View SEC Filing Icon  
11/30/2016Sell679$6.00$4,074.00994,032View SEC Filing Icon  
See Full Table

Stephen Brad Cohen Buying and Selling Activity at Sensus Healthcare

This chart shows Stephen Brad Cohen's buying and selling at Sensus Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sensus Healthcare Company Overview

Sensus Healthcare logo
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $3.29
Low: $3.24
High: $3.39

50 Day Range

MA: $3.89
Low: $3.14
High: $4.91

2 Week Range

Now: $3.29
Low: $1.79
High: $5.38

Volume

93,314 shs

Average Volume

150,962 shs

Market Capitalization

$53.92 million

P/E Ratio

109.70

Dividend Yield

N/A

Beta

0.91